312916-35-1 Usage
Category
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
A group of drugs that reduce inflammation, pain, and fever without the use of steroids.
Structural Relation
Ibuprofen
Shares a similar chemical structure with ibuprofen, another common NSAID.
4. Analgesic Properties
Reduces pain by raising the pain threshold and providing relief from discomfort.
5. Anti-inflammatory Properties
Decreases inflammation by inhibiting the production of prostaglandins, which contribute to the inflammatory response.
6. Antipyretic Properties
Reduces fever by lowering the body's temperature set point and promoting cooling.
Common Uses
Mild to moderate pain, fever, and inflammation
Utilized to alleviate symptoms associated with conditions like arthritis, menstrual cramps, and minor injuries.
Side Effects
Gastrointestinal irritation
Can cause stomach discomfort and other digestive issues, especially with long-term use or in individuals with pre-existing conditions.
Caution
Individuals with certain medical conditions
People with a history of gastrointestinal issues, kidney or liver problems, or other specific health concerns should use this drug with caution and consult a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 312916-35-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,2,9,1 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 312916-35:
(8*3)+(7*1)+(6*2)+(5*9)+(4*1)+(3*6)+(2*3)+(1*5)=121
121 % 10 = 1
So 312916-35-1 is a valid CAS Registry Number.
312916-35-1Relevant academic research and scientific papers
AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS
-
, (2008/06/13)
This invention relates to piperazine derivatives of formula (I), wherein Y is bond or lower alkylene, R1 is aryl which may have substituent(s), R2 is aryl or indolyl, each of which may have substituent(s), R3 is hydrogen or lower alkyl, and R4 is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to a use of the same for treating or preventing Tachykinin-mediated diseases in human beings or animals. 1
